Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008)

Pediatric Infectious Disease Journal

Volumn 31, Issue 3, 2012, Pages 278-283

  Jensen, Julia ^a   Álvaro Meca, Alejandro ^b   Micheloud, Dariela ^c,d   Díaz, Asunción ^e   Resino, Salvador ^c  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

epidemiology; HAART; HIV; Mycobacterium tuberculosis; nontuberculous mycobacteria; pediatrics

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; ATYPICAL MYCOBACTERIUM; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CHILD; CHILD HOSPITALIZATION; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MILIARY TUBERCULOSIS; MIXED INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM; OUTCOME ASSESSMENT; PERITONEUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SPAIN; TREND STUDY;

ADOLESCENT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PREVALENCE; RETROSPECTIVE STUDIES; SPAIN; TUBERCULOSIS;

EID: 84857627444     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e318239e268     Document Type: Article

References (38)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. Geneva, Switzerland: World Health Organization; 2009.
2. Buchacz K, Baker RK, Palella FJ Jr, et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS. 2010;24:1549-1559.
3. Lewden C, May T, Rosenthal E, et al. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr. 2008;48:590 -598.
4. Bonnet F, Chene G, Thiebaut R, et al. Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000-2004. HIV Med. 2007;8:547-554. (Pubitemid 47616834)
5. Gibb DM, Duong T, Tookey PA, et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland. BMJ. 2003;327:1019.
6. Resino S, Resino R, Maria Bellon J, et al. Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children. Clin Infect Dis. 2006;43:243-252.
7. Verhagen LM, Warris A, van Soolingen D, et al. Human immunodeficiency virus and tuberculosis coinfection in children: challenges in diagnosis and treatment. Pediatr Infect Dis J. 2010;29:e63-e70.
8. Harris TG, Li J, Hanna DB, et al. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005. Clin Infect Dis. 2010;50:1524-1531.
9. Braitstein P, Nyandiko W, Vreeman R, et al. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment. Pediatr Infect Dis J. 2009;28:626-632.
10. Cassidy PM, Hedberg K, Saulson A, et al. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis. 2009;49:e124-e129.
11. van Ingen J, Hoefsloot W, Dekhuijzen PN, et al. The changing pattern of clinical Mycobacterium avium isolation in the Netherlands. Int J Tuberc Lung Dis. 2010;14:1176-1180.
12. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest. 2008;133:243-251.
13. Hatherill M, Hawkridge T, Whitelaw A, et al. Isolation of non-tuberculous mycobacteria in children investigated for pulmonary tuberculosis. PLoS One. 2006;1:e21.
14. Brady MT, Oleske JM, Williams PL, et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr. 2010;53:86-94.
15. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197. (Pubitemid 30460862)
16. Vallecillo G, Sanvisens A, Martinez E, et al. Use of highly active antiretroviral therapy is increasing in HIV positive severe drug users. Curr HIV Res. 2010;8:641-648.
17. Viciana P, Rubio R, Ribera E, et al. Longitudinal study on adherence, treatment satisfaction, and effectiveness of once-daily versus twice-daily antiretroviral therapy in a Spanish cohort of HIV-infected patients (CUVA study) [in Spanish]. Enferm Infecc Microbiol Clin. 2008;26:127-134. (Pubitemid 351416484)
18. Alvaro-Meca A, Micheloud D, Jensen J, et al. Epidemiological trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008. Pediatr Infect Dis J. 2011;30:764-768.
19. Subdirección General de Desarrollo. Instituto Nacional de Salud. Ministerio de Sanidad y Consumo. Conjunto Mínimo Básico de Datos Hospitales de Insalud 2001. Available at: http://www.ingesa.msc.es/ estadEstudios/ documPublica/CMBD-2001.htm. 2001.
20. National Center for Health Statistics, Centers for Disease Control and Prevention. Classification of diseases, functioning, and disability. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Atlanta, GA: Centers for Disease Control and Prevention; 2008. Available at: http://www.cdc.gov/nchs/icd/icd9cm.htm.
21. Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296:292-300. (Pubitemid 44079313)
22. EuroTB. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006. Saint-Maurice, France: Institut de veille sanitaire; 2008. Available at: http://www.eurotb.org/.
23. Billinger ME, Olivier KN, Viboud C, et al. Nontuberculous mycobacteriaassociated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis. 2009;15:1562-1569.
24. ECDC/WHO. HIV/AIDS surveillance in Europe 2009. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2010. Available at: http://www.ecdc.europa.eu/en/Pages/home.aspx.
25. ECDC/WHO. Tuberculosis surveillance in Europe 2009. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2011. Available at: http://www.ecdc.europa.eu/en/Pages/home.aspx.
26. Diez M, Diaz A, Bleda MJ, et al. Prevalence of M. tuberculosis infection and tuberculosis disease among HIV-infected people in Spain. Int J Tuberc Lung Dis. 2007;11:1196-1202. (Pubitemid 350146300)
27. Castilla J, Gutierrez A, Guerra L, et al. Pulmonary and extrapulmonary tuberculosis at AIDS diagnosis in Spain: epidemiological differences and implications for control. AIDS. 1997;11:1583-1588. (Pubitemid 27460247)
28. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990s. Clin Microbiol Rev. 2003;16:319-354. (Pubitemid 36519815)
29. Resino S, Resino R, Micheloud D, et al. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up. Clin Infect Dis. 2006;42:862-869. (Pubitemid 43363946)
30. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402. (Pubitemid 38624845)
31. Sanchez-Albisua I, Baquero-Artigao F, Del Castillo F, et al. Twenty years of pulmonary tuberculosis in children: what has changed? Pediatr Infect Dis J. 2002;21:49-53. (Pubitemid 34073959)
32. Cruz AT, Starke JR. Pediatric tuberculosis. Pediatr Rev. 2010;31:13-25.
33. Newton SM, Brent AJ, Anderson S, et al. Paediatric tuberculosis. Lancet Infect Dis. 2008;8:498-510. (Pubitemid 352001412)
34. Muga R, Ferreros I, Langohr K, et al. Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS. 2007;21:2521-2527. (Pubitemid 350145184)
35. Resino S, Sanchez-Ramon S, Bellon JM, et al. Immunological recovery after 3 years' antiretroviral therapy in HIV-1-infected children. AIDS. 2002;16:483-486. (Pubitemid 34165382)
36. Walls T, Shingadia D. Global epidemiology of paediatric tuberculosis. J Infect. 2004;48:13-22. (Pubitemid 38072198)
37. Diez M, Huerta C, Moreno T, et al. Tuberculosis in Spain: epidemiological pattern and clinical practice. Int J Tuberc Lung Dis. 2002;6:295-300. (Pubitemid 34263685)
38. Multicenter Project of Tuberculosis Research (MPTR) Working Group. Tuberculosis in Spain: results of the Multicenter Project for Tuberculosis Research. Madrid, Spain: Instituto de salud Carlos III; 1999.